NCT05594927 2024-08-07
BESTPOP
Beijing Shenogen Biomedical Co., Ltd
Phase 3 Recruiting
Clinical Trials
3 trialsNCT03236649 2023-02-08
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
Beijing Shenogen Biomedical Co., Ltd
Phase 3 Terminated
NCT01972672 2021-01-27
The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma
Beijing Shenogen Biomedical Co., Ltd
Phase 2 Completed